BR0317413A - Uso de tiazolobenzoheterociclos para o tratamento de esclerose múltipla - Google Patents

Uso de tiazolobenzoheterociclos para o tratamento de esclerose múltipla

Info

Publication number
BR0317413A
BR0317413A BR0317413-1A BR0317413A BR0317413A BR 0317413 A BR0317413 A BR 0317413A BR 0317413 A BR0317413 A BR 0317413A BR 0317413 A BR0317413 A BR 0317413A
Authority
BR
Brazil
Prior art keywords
multiple sclerosis
thiazolobenzoheterocycles
treatment
inflammatory
compound
Prior art date
Application number
BR0317413-1A
Other languages
English (en)
Inventor
Bin Zhu
Joseph Wettstein
Margaret Petty
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BR0317413A publication Critical patent/BR0317413A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"USO DE TIAZOLOBENZOHETEROCICLOS PARA O TRATAMENTO DE ESCLEROSE MúLTIPLA". A presente invenção refere-se ao uso de um composto de Fórmula I para fabricar um medicamento para o tratamento de pacientes para dor inflamatória ou neuropática assim como de vários sintomas de esclerose múltipla.
BR0317413-1A 2002-12-17 2003-12-16 Uso de tiazolobenzoheterociclos para o tratamento de esclerose múltipla BR0317413A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43400302P 2002-12-17 2002-12-17
PCT/US2003/040078 WO2004058271A1 (en) 2002-12-17 2003-12-16 Use of thiazolobenzoheterocycles for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
BR0317413A true BR0317413A (pt) 2005-11-08

Family

ID=23722415

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317413-1A BR0317413A (pt) 2002-12-17 2003-12-16 Uso de tiazolobenzoheterociclos para o tratamento de esclerose múltipla

Country Status (10)

Country Link
US (1) US7041661B2 (pt)
EP (1) EP1585525B1 (pt)
AT (1) ATE488238T1 (pt)
AU (1) AU2003300976A1 (pt)
BR (1) BR0317413A (pt)
CA (1) CA2508222A1 (pt)
DE (1) DE60335029D1 (pt)
GB (1) GB0307067D0 (pt)
MX (1) MXPA05006296A (pt)
WO (1) WO2004058271A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012502915A (ja) 2008-09-15 2012-02-02 バイオビスタ インコーポレイテッド てんかんを治療する組成物及び方法
US20150018362A1 (en) 2012-02-27 2015-01-15 Biovista, Inc. Compositions and methods for treating mitochondrial diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649701B2 (fr) 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
FR2766487B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
FR2826004B1 (fr) 2001-06-13 2008-03-28 Aventis Pharma Sa Procede de preparation de derives estrogenes

Also Published As

Publication number Publication date
EP1585525A1 (en) 2005-10-19
AU2003300976A1 (en) 2004-07-22
US7041661B2 (en) 2006-05-09
WO2004058271A1 (en) 2004-07-15
CA2508222A1 (en) 2004-07-15
DE60335029D1 (de) 2010-12-30
EP1585525B1 (en) 2010-11-17
GB0307067D0 (en) 2003-04-30
ATE488238T1 (de) 2010-12-15
US20040147504A1 (en) 2004-07-29
MXPA05006296A (es) 2005-08-29

Similar Documents

Publication Publication Date Title
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
NO20063064L (no) Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte
TW200630367A (en) Substituted adenines and the uses thereof
EA201001455A1 (ru) Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3)
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
ECSP055844A (es) Nuevos compuestos triciclicos
ECSP024244A (es) Uso de (z)-2-cyano-3-hydroxy-but-2-enoic acid(4´-trifluoromethylphenyl)-amide para el tratamiento de la esclerosis múltiple
MXPA05008438A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6.
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
NO20033959D0 (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
DE60232173D1 (de) Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
SE0004101D0 (sv) New use
SE0002739D0 (sv) New use
BR0317413A (pt) Uso de tiazolobenzoheterociclos para o tratamento de esclerose múltipla
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
BRPI0409586A (pt) ácidos hidroxámicos úteis no tratamento de distúrbios hiperproliferativos
SE0300907D0 (sv) Novel compounds
BR0317445A (pt) Composto, composição farmacêutica, método para o tratamento de doenças, e, uso de um composto
ATE431348T1 (de) Thiaepothilone zur behandlung von krebserkrankungen
IL164536A0 (en) The use of hydroxypyridone-derivatives in wound healing
NO20070058L (no) Amino-halogen-imidazopyridiner som protonpumpeinhibitorer
DE60322343D1 (de) Spermidin derivate zur behandlung chronischer neurodegerenativer krankheiten
SE0300906D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]